Woodline Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50,000
| Closed | -$2.56M | – | 926 |
|
|
2024
Q4 | $2.56M | Buy |
+50,000
| New | +$2.56M | 0.02% | 615 |
|
|
2024
Q2 | – | Sell |
-153,395
| Closed | -$7.18M | – | 578 |
|
|
2024
Q1 | $7.18M | Buy |
153,395
+3,395
| +2% | +$159K | 0.07% | 316 |
|
|
2023
Q4 | $5.34M | Hold |
150,000
| – | – | 0.06% | 310 |
|
|
2023
Q3 | $4.46M | Buy |
+150,000
| New | +$4.46M | 0.05% | 326 |
|